middle.news
How Tetratherix’s TetraDerm Is Poised to Transform Scar Prevention in Major Surgery
8:36am on Tuesday 13th of January, 2026 AEDT
•
Healthcare
Read Story
How Tetratherix’s TetraDerm Is Poised to Transform Scar Prevention in Major Surgery
8:36am on Tuesday 13th of January, 2026 AEDT
Key Points
Second cohort of TetraDerm trial completed with zero adverse events
Trial advances to third and final cohort focusing on body contouring patients
TetraDerm aims to prevent scarring in major surgical incisions
Strong safety profile supports potential for high-volume reconstructive surgery market
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Tetratherix (ASX:TTX)
OPEN ARTICLE